Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Functional nitric oxide synthase mislocalization in cardiomyopathy.

Ahlke Heydemann1, Jill M Huber, Rahul Kakkar

  • 1Department of Medicine, Section of Cardiology, The University of Chicago, 5841 S. Maryland, MC6088, Rm G611, Chicago, IL 60637, USA.

Journal of Molecular and Cellular Cardiology
|February 12, 2004
PubMed
Summary

Mutations in sarcoglycans cause heart damage and muscular dystrophy. Inhibiting nitric oxide synthase (NOS) improved cardiac function in mutant mice by correcting abnormal nitric oxide (NO) levels.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Additive value of polygenic risk and family history for coronary heart disease risk stratification in two diverse US cohorts.

American journal of human genetics·2026
Same author

49-Year-Old Woman With Widespread Rash and Unilateral Vision Loss.

Mayo Clinic proceedings·2026
Same author

Excess muscle plasma membrane leak disrupts extracellular matrix content and shifts macrophage-mediated muscle repair.

JCI insight·2026
Same author

Engineered Heart Tissues Facilitate Noncoding Variant Studies in Cardiomyopathy.

Circulation research·2026
Same author

Motivations for pursuing multiple genetic risk assessments and responses to receiving identical risk results.

Journal of genetic counseling·2026
Same author

Return of genome-informed risk-assessment results for common conditions to 23,840 adults and children: An eMERGE network study.

American journal of human genetics·2026

Area of Science:

  • Cardiovascular Biology
  • Muscle Physiology
  • Molecular Genetics

Background:

  • Dystrophin glycoprotein complex mutations, particularly in sarcoglycans, are linked to cardiomyopathy and muscular dystrophy.
  • Sarcoglycan mutations in mice result in focal cardiac tissue damage and altered cellular function.

Purpose of the Study:

  • To investigate the role of nitric oxide (NO) in sarcoglycan-deficient cardiomyopathy.
  • To determine if modulating NO production can ameliorate cardiac dysfunction in these models.

Main Methods:

  • Utilized mouse models with gamma-sarcoglycan or delta-sarcoglycan mutations.
  • Measured endothelial nitric oxide synthase (eNOS) and NO levels in cardiac tissue.
  • Assessed cardiac function through carbachol and isoproterenol stimulation.

Related Experiment Videos

  • Evaluated the effects of nitric oxide synthase inhibition on cardiac recovery.

    • Main Results:

    • Increased eNOS and NO were observed in focally damaged cardiac myocytes of mutant mice.
    • Regional NO elevation correlated with hypersensitivity to carbachol and reduced adrenergic response.
    • Inhibition of NO production improved cardiac recovery following pharmacological stimulation.

    Conclusions:

    • Focal cardiac damage in sarcoglycan mutant mice creates pathological NO gradients.
    • Modulating NO production via NOS inhibition offers a therapeutic strategy for sarcoglycanopathies.